profitability milestone

InnoCare Pharma achieved 644 million yuan profit in 2025, two years ahead of schedule, driven by product sales and licensing partnerships. Hong Kong-listed shares trade at modest 14x P/S ratio.

SpaceX targets mid-2026 IPO at $1.5T valuation as Rocket Lab ($RKLB) and Planet Labs ($PL) surge 230% and 700% respectively, signaling robust space sector growth.